Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ILY101 in CKD patients with hyperphosphatemia on hemodialysis
NCT00358046Phase 2Unknown
- Sponsor
- Ilypsa
- Start
- Jun 2006
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bixalomer in hyperphosphatemia, sponsored by Ilypsa. Status: unknown.
02
Drugs
bixalomer
03
Conditions
hyperphosphatemia
Beyond the preview
Go deeper on NCT00358046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00358046.